257 related articles for article (PubMed ID: 11353132)
1. Quantitative evaluation of urinary porphyrins as a measure of kidney mercury content and mercury body burden during prolonged methylmercury exposure in rats.
Pingree SD; Simmonds PL; Rummel KT; Woods JS
Toxicol Sci; 2001 Jun; 61(2):234-40. PubMed ID: 11353132
[TBL] [Abstract][Full Text] [Related]
2. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on tissue and urine mercury levels following prolonged methylmercury exposure in rats.
Pingree SD; Simmonds PL; Woods JS
Toxicol Sci; 2001 Jun; 61(2):224-33. PubMed ID: 11353131
[TBL] [Abstract][Full Text] [Related]
3. Urinary porphyrin profiles as biomarkers of trace metal exposure and toxicity: studies on urinary porphyrin excretion patterns in rats during prolonged exposure to methyl mercury.
Woods JS; Bowers MA; Davis HA
Toxicol Appl Pharmacol; 1991 Sep; 110(3):464-76. PubMed ID: 1949014
[TBL] [Abstract][Full Text] [Related]
4. Altered porphyrin metabolism as a biomarker of mercury exposure and toxicity.
Woods JS
Can J Physiol Pharmacol; 1996 Feb; 74(2):210-5. PubMed ID: 8723034
[TBL] [Abstract][Full Text] [Related]
5. Urinary porphyrin profiles as a biomarker of mercury exposure: studies on dentists with occupational exposure to mercury vapor.
Woods JS; Martin MD; Naleway CA; Echeverria D
J Toxicol Environ Health; 1993; 40(2-3):235-46. PubMed ID: 8230299
[TBL] [Abstract][Full Text] [Related]
6. Urinary porphyrins as biological indicators of oxidative stress in the kidney. Interaction of mercury and cephaloridine.
Miller DM; Woods JS
Biochem Pharmacol; 1993 Dec; 46(12):2235-41. PubMed ID: 8274157
[TBL] [Abstract][Full Text] [Related]
7. Effect of DMPS and DMSA on the placental and fetal disposition of methylmercury.
Bridges CC; Joshee L; Zalups RK
Placenta; 2009 Sep; 30(9):800-5. PubMed ID: 19615742
[TBL] [Abstract][Full Text] [Related]
8. Increase of renal excretion of organo-mercury compounds like methlymercury by DMPS (2,3-Dimercapto-1-propanesulfonic acid, Dimaval).
Drasch G; Boese-O'Reilly S; Illig S
Clin Toxicol (Phila); 2007; 45(3):266-9. PubMed ID: 17453878
[TBL] [Abstract][Full Text] [Related]
9. Mobilization of mercury by DMPS in occupationally exposed workers and in model experiments on rats: evaluation of body burden.
Nerudová J; Cábelková Z; Frantík E; Lukás E; Urban P; Bláha K; Pelclová D; Lebedová J; Cikrt M
Int J Occup Med Environ Health; 2000; 13(2):131-46. PubMed ID: 10967843
[TBL] [Abstract][Full Text] [Related]
10. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico.
Gonzalez-Ramirez D; Maiorino RM; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Aposhian MM; Dart RC; Diaz Gama JH; Echeverria D
J Pharmacol Exp Ther; 1995 Jan; 272(1):264-74. PubMed ID: 7815341
[TBL] [Abstract][Full Text] [Related]
11. Effects of 2,3-dimercapto-1-propanesulfonic acid (DMPS) on methylmercury-induced locomotor deficits and cerebellar toxicity in mice.
Carvalho MC; Franco JL; Ghizoni H; Kobus K; Nazari EM; Rocha JB; Nogueira CW; Dafre AL; Müller YM; Farina M
Toxicology; 2007 Oct; 239(3):195-203. PubMed ID: 17703864
[TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of porphyrins in rat and human urine and evaluation of urinary porphyrin profiles during mercury and lead exposures.
Bowers MA; Aicher LD; Davis HA; Woods JS
J Lab Clin Med; 1992 Aug; 120(2):272-81. PubMed ID: 1500825
[TBL] [Abstract][Full Text] [Related]
13. Influence of 2,3-dimercaptopropane-1-sulfonate (DMPS) and meso-2,3-dimercaptosuccinic acid (DMSA) on the renal disposition of mercury in normal and uninephrectomized rats exposed to inorganic mercury.
Zalups RK
J Pharmacol Exp Ther; 1993 Nov; 267(2):791-800. PubMed ID: 8246154
[TBL] [Abstract][Full Text] [Related]
14. MRP2 and the DMPS- and DMSA-mediated elimination of mercury in TR(-) and control rats exposed to thiol S-conjugates of inorganic mercury.
Bridges CC; Joshee L; Zalups RK
Toxicol Sci; 2008 Sep; 105(1):211-20. PubMed ID: 18511429
[TBL] [Abstract][Full Text] [Related]
15. Chelation of lead by dimercaptopropane sulfonate and a possible diagnostic use.
Twarog T; Cherian MG
Toxicol Appl Pharmacol; 1984 Mar; 72(3):550-6. PubMed ID: 6710504
[TBL] [Abstract][Full Text] [Related]
16. [Experimental study on the effects of BSO, GSH, vitamin C and DMPS on the nephrotoxicity induced by mercury].
Zhao-Fa X; Jing-Hua Y; Jia-Ming Y; Zhong-Wei Y
Wei Sheng Yan Jiu; 2005 Sep; 34(5):533-6. PubMed ID: 16329589
[TBL] [Abstract][Full Text] [Related]
17. MRP2 involvement in renal proximal tubular elimination of methylmercury mediated by DMPS or DMSA.
Zalups RK; Bridges CC
Toxicol Appl Pharmacol; 2009 Feb; 235(1):10-7. PubMed ID: 19063911
[TBL] [Abstract][Full Text] [Related]
18. Complexing activity of 2,3-dimercapto-1-propanesulfonate and its disulfide auto-oxidation product in rat kidney.
Diamond GL; Klotzbach JM; Stewart JR
J Pharmacol Exp Ther; 1988 Jul; 246(1):270-4. PubMed ID: 3392658
[TBL] [Abstract][Full Text] [Related]
19. Inorganic mercury poisoning associated with skin-lightening cosmetic products.
Chan TY
Clin Toxicol (Phila); 2011 Dec; 49(10):886-91. PubMed ID: 22070559
[TBL] [Abstract][Full Text] [Related]
20. Mobilization of mercury and arsenic in humans by sodium 2,3-dimercapto-1-propane sulfonate (DMPS).
Aposhian HV
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1017-25. PubMed ID: 9703487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
